Press Releases

May 30, 2025

Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Canada cannabis revenue increased 4% in Q4 FY2025 year-over-year, led by 13% growth in Canada medical cannabis Reduced total debt by $293 million or 49% during FY2025 Refined strategy, focus and organizational structure expected to accelerate growth in global medical cannabis and improve commercial execution in Canada adult-use cannabis Additional cost reduction initiatives identified and initiated in Q4 FY2025 are expected to deliver at least $20 million in annualized savings over the next 12-18 months Read our fiscal year and fourth quarter 2025 financial results here: SMITHS FALLS, ON, May 30, 2025 – Canopy Growth Corporation (“Canopy Growth” or the…

May 16, 2025

Canopy Growth to Report Fourth Quarter and Fiscal Year 2025 Financial Results on May 30, 2025

Smiths Falls, ON, May 16, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the fourth quarter and fiscal year 2025 ended March 31, 2025 before financial markets open on May 30, 2025. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on May 30, 2025 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=1235414F-AB39-4A0B-871E-B1885B487ACD Replay Information A replay will be accessible by webcast…

May 6, 2025

Canopy Growth Drives Innovation in High-Demand Segments with Latest Product Launches

Offerings reflect a focused format strategy in Canada’s adult-use market Vapes, high-THC flower, pre-roll joints, and edibles introduced across core brands SMITHS FALLS, ON. May 6, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched a series of product innovations targeting Canada’s fastest-growing adult-use categories[1]. The lineup reflects a focused strategy built around four high-demand formats: vapes, high-THC flower, pre-rolls (including infused), and edibles. This fresh lineup strengthens Canopy’s presence in core formats and is backed by its flagship…

April 2, 2025

Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency SMITHS FALLS, ON. April 2, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand in Canada. Designed to meet the evolving needs of medical cannabis patients, Spectrum Reserve represents the peak of cannabis cultivation – featuring flower selected for size, potency, and terpene levels through rigorous in-house standards during cultivation and post-harvest. Under this new program, Spectrum Reserve is expected…

April 1, 2025

Canopy Growth Strengthens Balance Sheet with Optional Early Prepayment to Reduce Term Loan by US$100 Million

Early Prepayment Reduces Annual Interest Expense by US$13 Million, Extends Maturity of Term Loan to September 2027 This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated June 6, 2024 to its short form base shelf prospectus dated February 28, 2025 SMITHS FALLS, ON. April 1, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that it has made an optional early prepayment under its senior secured term loan (the…

February 28, 2025

Canopy Growth Establishes New US$200 Million At-The-Market Program

Net proceeds expected to be used for corporate purposes including paying down debt, strengthening the Company’s cash position, and supporting strategic M&A SMITHS FALLS, ON. February 28, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that the Company has established a new at-the-market equity program (the “ATM Program”) that allows Canopy Growth to issue and sell up to US$200 million (or its Canadian dollar equivalent) of common shares of the Company (“Common Shares”) from treasury from time to…

February 27, 2025

Canopy Growth Announces Entry of Tweed Brand to German Medical Cannabis Market

Four new Tweed strains available through an agreement with Portugal-based Gro-Vida Tweed Glitter Bomb strain launched in December 2024 through an agreement with German-based Cansativa Smiths Falls, Ontario, February 27, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has officially launched its Tweed brand in the German medical cannabis market, including the availability of four new Tweed strains grown in the EU through an agreement with Gro-Vida S.A (Gro-Vida), a Portuguese medical cannabis cultivator. Born in Canada more than a…

February 13, 2025

Canopy Growth Expands Deep Space Propulsion Beverage Lineup with Two New Flavours: Rocket Root Beer and Charged Cream Soda

Together with Blue Sourberry and Altitude Lemon Lime, Deep Space Propulsion Continues to Pioneer the High-Potency Cannabis Beverage Category with its Expanded Portfolio of Innovative Flavours SMITHS FALLS, ONTARIO February 13 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today the expansion of its Deep Space Propulsion beverage lineup with two new flavours: Rocket Root Beer and Charged Cream Soda. Proudly developed in Canada, these innovative takes on classic flavours join Blue Sourberry and Altitude Lemon Lime, rounding out a…

February 7, 2025

Canopy Growth Reports Third Quarter Fiscal Year 2025 Financial Results

Strong holiday sales drove Storz & Bickel net revenue growth of 19% year-over-year Record quarter for Canada medical cannabis with net revenue increasing 16%; international markets cannabis net revenue grew 14% year-over-year Successfully launched Claybourne infused pre-rolls across Canada, Claybourne rose to #3 market share in the infused pre-roll category in British Columbia and Ontario after 6 weeks in market1 SMITHS FALLS, ON, February 7, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (Nasdaq: CGC) today announces its financial results for the third fiscal quarter ended December 31, 2024 (“Q3 FY2025″). All financial information in this press…

January 24, 2025

Canopy Growth to Report Third Quarter Fiscal 2025 Financial Results on February 7, 2025

Smiths Falls, ON, January 24, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the third quarter fiscal year 2025 ended December 31, 2024 before financial markets open on February 7, 2025. Following the release of its third quarter fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on February 7 at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://app.webinar.net/yY1K7LrWq9O Replay Information A replay will be accessible by webcast until 11:59 PM…
Scroll to Top
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.